A matrix metalloproteinase inhibitor reduces bone-type collagen degradation fragments and specific collagenases in gingival crevicular fluid during adult periodontitis

Inflammation Research

Volumn 46, Issue 8, 1997, Pages 310-319

  Golub, L M ^a   Lee, H M ^a   Greenwald, R A ^b   Ryan, M E ^a   Sorsa, T ^c   Salo, T ^d   Giannobile, W V ^e  

^a STONY BROOK UNIVERSITY   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Bone resorption; Collagenase; Gingival crevicular fluid; Periodontitis; Protease inhibitor

Indexed keywords

COLLAGEN TYPE 1; COLLAGENASE; DOXYCYCLINE; MATRIX METALLOPROTEINASE INHIBITOR; METALLOPROTEINASE; OSTEOCALCIN;

ADULT; AGED; ARTICLE; BONE ATROPHY; CLINICAL ARTICLE; CLINICAL TRIAL; COLLAGEN DEGRADATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GINGIVITIS; HUMAN; IMMUNOBLOTTING; MALE; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; PERIODONTITIS; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BONE AND BONES; COLLAGEN; COLLAGEN TYPE I; COLLAGENASES; DOXYCYCLINE; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; LONGITUDINAL STUDIES; MALE; MATRIX METALLOPROTEINASE 8; METALLOENDOPEPTIDASES; MIDDLE AGED; OSTEOCALCIN; PEPTIDE FRAGMENTS; PEPTIDES; PERIODONTITIS;

EID: 0030862107     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050193     Document Type: Article

References (69)

1. Page R. The role of inflammatory mediators in the pathogenesis of periodontal disease. J Periodont Res 1991;36:230-9.
2. Birkedal-Hansen H. Role of matrix metalloproteinases in human periodontal diseases. J Periodont 1993;64:474-84.
3. Lee W, Aitken S, Sodek J, McCulloch C, Evidence of a direct relationship between neutrophil collagenase activity and periodontal tissue destruction in vivo: role of active enzyme in human periodontitis. J Periodont Res 1995;30:23-33.
4. Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opinion Periodont 1996;3:85-96.
5. Jeffcoat MK, Williams RC, Reddy MS, English R, Goldhaber P. Flurbiprofen treatment of human periodontitis: effect on alveolar bone height and metabolism. J Periodont Res 1988;23:381-7.
6. Williams RC, Jeffcoat MK, Howell TH, Rolla A, Scribbs D, Teoh KW, et al. Altering the progession of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodont 1989;60:486-90.
7. Golub LM, Wolff M, Roberts S, Lee HM, Leung M, Payonk G. Treating periodontal diseases by blocking tissue-destructive enzymes. J Am Dent Ass 1994;125:163-9.
8. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R. Minocycline reduces gingival collagenolytic activity during diabetes: preliminary observations and a proposed new mechanism of action. J Periodont Res 1983;18:516-26.
9. Golub LM, Suomalainen K, Sorsa T, Host modulation with tetracyclines and their chemically modified analogues. Curr Opin Dent 1992;2:80-90.
10. Greenwald RA, Tetracyeline derivatives as potential inhibitors of connective tissue degradation. Drug News & Perspectives 1990;3:161-6.
11. Golub LM, Ciancio S, Ramamurthy NS, Leung M, McNamara TF, Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodont Res 1990;25:321-30.
12. Crout RJ, Lee HM, Schroeder K, Crout H, Ramamurthy NS, Wiener M, et al. The "cyclic" regimen of low-dose doxycycline for adult periodontitis: a preliminary study. J Periodont 1996;67:506-14.
13. Golub LM, Sorsa T, Lee HM, Ciancio S, Sorbi D, Ramamurthy NS, Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodont 1995;21:1-9.
14. Schroeder K, Ramamurthy NS, Tofil P, Smith R, Lee HM, Golub LM, Low-dose doxycycline prevents attachment loss in adult periodontitis [abstract]. J Dent Res 1992;71 (Spec. Issue):IADR 1936A.
15. Bouwsma O, Payonk G, Baron H, Sipos T, Low-dose doxycycline: effects on clinical parameters in adult periodontitis (abstract). J Dent Res 1992;71 (Spec. Issue):AADR 1119.
16. Bouwsma O, Payonk G, Baron H, Sipos T, Low-dose doxycycline reduces GCF collagenase in adult periodontitis [abstract]. J Dent Res 1992;71 (Spec. Issue):AADR 1120.
17. Thomas J, Crout R, Crout H, Cook D, Keating J, Casto G, et al. Antibiotic resistance evalution with low-dose doxycycline (LDD) in adult periodontilis [abstract]. J Dent Res 1995;74 (Spec. Issue): IADR 1394A.
18. Goren AD, Dunn SM, Wolff M, Weiner M, McNamara T, Golub LM, el al. Effect of a 6-month regimen of low-dose doxycycline on alveolar bone loss in adult periodontilis patients: preliminary evaluation of digital subtraction results. Proceedings of the 45th meeting of the Amer Acad Oral and Maxillofac Radiology; 1994 Nov; New Orleans (LA):73.
19. Caton J. Blieden T, Adams D, Crout R, Hefti A, Killoy W, et al. Subantimicrobial doxycycline therapy for periodontitis [abstract]. J Dent Res 1997;76 (Spec. Issue):IADR 1307A.
20. 2-macroglobulin levels are elevated in gingival crevicular fluid during human orthodontic tooth movement. J Dent Res 1996;75:562-7.
21. Greenwald RA. Monitoring collagen degradation in patients with arthritis: The search for suitable surrogates. Arthritis Rheum 1996;39:1455-65.
22. Garnero P, Grimaux M, Sequin P, Delmas PD. Characterization of immunoreactive forms of humans osteocalcin generated in vivo and in vitro. J Bone Min Res 1994;9:255-64.
23. Giannobile WV, Lynch SE, Denmark RG, Paquette DW, Fiorellini JP, Williams RC. Crevicular fluid osteocalcin and pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) as markers of rapid bone turnover in periodontitis. J Clin Periodontol 1995;22:903-10.
24. Giannobile WV, Palys M, Howell TH, Haffajee AD, Socransky SS, Crevicular fluid ICTP in patients with periodontitis [abstract], J Dent Res 1996;75 (Spec. Issue):IADR 1114A.
25. Risteli J, Elomaa I, Niemi S, Novamo A, Risteli I. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptide of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;39:635-40.
26. Talonpoika JT, Hamalainen MM. Type 1 collagen carboxyterminal telopeptide in human gingival crevicular fluid in different clinical conditions and after periodontal treatment. J Clin Periodontol 1994;21:320-6.
27. Kunimatsu K, Mataki S, Tanaka H, Mine N, Kiyoki M, Hosoda K, et al. A cross-sectional study on osteocalein levels in gingival crevicular fluid from periodontal patients. J Periodent 1993;64:865-9.
28. 2 and alkaline phosphatase in gingival crevicular fluid: their relations to periodontal status. J Clin Periodontol 1994;21:327-33.
29. Loe H, Silness P. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odont Scand 1963;21:533-51.
30. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odont Scand 1964;22:121-35.
31. Sorsa T, Ding Y, Salo T, Lauhio A, Teronen O, Ingman T, et al. Effects of tetracyclines on neutrophil, gingival and salivary collagenases. A functional and western blot assessment with special reference to their cellular sources in periodontal diseases. Ann NY Acad Sci 1994;732:112-31.
32. Lauhio A, Salo T, Ding Y, Konttinen YT, Nordstrom D, Tschesche H, et al. In vivo inhibition of human neutrophil collagenase (MMP-8) actively during long-term combination therapy with doxycycline and NSAID in acute reactive arthritis. Clin Exp Immunol 1994;98:21-8.
33. Ingman T, Tewarhartiala T, Ding Y, Tschesche H, Haerlan A, Kinane DF. Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol 1996;23:1127-32.
34. Golub LM, Evans R, McNamara TF, Lee HM, Ramamurthy NS. A non-antimicrobial tetracycline inhibits gingival matrix metalloproteinases and bone loss in Porphyromonas gingivalis-induced periodontitis in rats. Ann NY Acad Sci 1994;732:96-111.
35. Golub LM, Ramamurthy NS, McNamara TF, Greenwald RA, Rifkin BR. Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs. Crit Revs Oral Biol Med 1991;2:297-322.
36. Ryan ME, Greenwald RA, Golub LM. Potential of tetracyclines to modify cartilage breakdown in osteoarthritis. Curr Opin Rheutnatol 1996;8:238-47.
37. Burns FR, Stack MS, Gray RD, Paterson CA. Inhibition of purified collagenase from alkaline-burned rabbit corneas. Investive Ophthal Vis Sci 1989;30:1569-75.
38. Sorsa T, Lindy O, Konttinen YT, Suomalainen T, Ingman T, Saari H, et al. Doxycycline in the protection of serum alpha-1-antitrypsin from human neutrophil collagenase and gelatinase. Antimicrob Agents Chemother 1993;37:592-4.
39. 1-proteinase inhibitor in gingival crevicular fluid of humans with adult periodontitis: serpinolytic inhibition by doxycycline. J Periodont Res 1997;32:9-19.
40. Schneir M, Ramamurthy NS, Golub LM. Minocycline treatment of diabetic rats increases skin collagen production and mass. Matrix 1990;10:112-23.
41. Sasaki T, Ramamurthy NS, Golub LM. Tetracycline administration restores osteoblast structure and function during experimental diabetes. Anal Rec 1991;231:25-34.
42. Sasaki T, Ramamurthy NS, Golub LM. Tetracycline administration increases collagen synthesis in osteoblasts of streptozotocininduced diabetic rats: a quantitative autoradiographic study. Calc Tissue Int 1992;50:411-9.
43. Seibel MJ. Biochemical markers of bone formation and bone resorption. In: Biologie Prospective. Comptes rendus due 8° Colloque de Pont-a-Mousson. editors Galteau MM, Siest G, Henney J. Paris. J Libbey Eurotext. 1993;275-81.
44. Hakala M, Risteli L, Manelius J, Nieminen P, Risteli J. Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis. Ann Rheum Dis 1993;52:866-9.
45. Kotaniemi A, Isomaki H, Hakala M, Risteli L, Risteli J. Increased type I collagen degradation in early rheumatoid arthritis. J Rheumatol 1994;21:1593-6.
46. Lamster IB, Oshrain RK, Harper DS, Celenti RS, Hovliaris CA, Gordon JM. Enzyme activity in crevicular fluid for detection and prediction of clinical attachment loss in patients with chronic adult periodontitis. J Periodont 1988;59:516-23.
47. Fine DH, Mandel I. Indicators of periodontal disease activity: an evaluation. J Clin Periodontol 1986;13:533-46.
48. Rifkin BR, Vernillo AT, Golub LM, Ramamurthy NS. Modulation of hone resorption by tetracyclines. Ann NY Acad Sci 1994;732:165-80.
49. Ganu U, Doughty J, Spirito S, Goldberg R. Elevation of urinary pyridinoline and its inhibition by doxycycline. Ann NY Acad Sci 1994;732:416-8.
50. Greenwald RA. Treatment of destructive arthritic disorders with MMP inhibitors. Ann NY Acad Sci 1994;732:181-98.
51. Golub LM, Siegal K, Ramamurthy NS, Mandel ID. Some characteristics of collagenase in gingival crevicular fluid and its relationship to gingival disease in humans. J Dent Res 1976;55:1049-57.
52. Ditto VJ, Suomalainen K, Sorsa T. Salivary collagenase. Origin, characteristics and relationship to periodontal health. J Periodont Res 1990;25:135-42.
53. Gangbar S, Overall CM, McCulloch CA, Sodek J. Identification of polymorphonuclear leukocyte collagenase and gelatinase activities in mouthrinse samples: correlations with periodontal disease activity in adult and juvenile periodontitis. J Periodont Res 1990;25:257-67.
54. Kryshtalskyj E, Sodek J, Ferrier JM. Correlation of collagenolytic enzymes and inhibitors in gingival crevicular fluid with clinical and microscopic changes in experimental periodontitis in the dog. Archs Oral Biol 1986;31:21-31.
55. Teng YT, Sodek J, McCulloch CAG. Gingival crevicular fluid gelatinase and its relationship to periodontal disease in human subjects. J Periodont Res 1992;27:544-52.
56. McCulloch CAG. Host enzymes in gingival crevicular fluid as diagnostic indicators of periodontitis. J Clin Periodontol 1994;21:497-506.
57. Overall CM, Sodek J, McCulloch CA, Birek P. Evidence for polymorphonuclear leukocyte collagenase and 92-kilodalton gelatinase in gingival crevicular fluid. Infect Immunity 1991;59:4687-92.
58. Sorsa T, Uitlo VJ, Suomalainen K, Vaukhonen M, Lindy S. Comparison of interstitial collagenases from human gingiva, sulcular fluid and polymorphonuclear leukocytes. J Periodont Res 1988;23:386-93.
59. Chubinskaya S, Huch K, Mikecz K, Cs-Szabo G, Hasty KA, Kuettner KE, et al. Chrondroeyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1β in human cartilage joints from knee and ankle joints. Lab Invest 1996;74:232-40.
60. Cole AA, Chubinskaya S, Schumacher B, Huch K, Cs-Szabo G, Yao J, et al. Chondrocyte matrix metalloproleinase-8. J Biol Chem 1996;271:11023-6.
61. Martel-Pelletier J, Pelletier J-P. Wanted - the collagenase responsible for the destruction of the collagen network in human cartilage. Brit. J Rheumatol 1996;35:818-20.
62. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544-50.
63. Smith GN Jr, Mickler EA, Hasty KA, Brandt KD. Inhibition by doxycycline of a truncated form of recombinant human MMP-13. Arthritis Rheum 1996;39 Suppl 9;S226.
64. Williams S, Wakisaka A, Zeng QQ, Barnes J, Martin G, Wechter WJ, et al. Minocycline prevents the decrease in bone mineral density and trahecular bone in ovariectomized aged rats. Bone 1996;19:637-44.
65. Aoyagi M, Sasaki T, Ramamurthy NS, Golub LM. Tetracycline/ flurbiprofen combination therapy modulates bone remodeling in ovariectomized rats: preliminary observations. Bone 1996;19:629-35.
66. Greenwald RA, Golub LM, Choudhury M, Ramamurthy NS, Moak SA, Sorsa T. In vitro sensitivity of the three mammalian collagenases to tetracycline inhibition: relationship to bone and cartilage degradation. Bone 1997;submitted.
67. Haerian A, Adonogianaki E, Mooney J, Docherty JP, Kinane DF. Gingival crevicular stromelysin, collagenase and tissue inhibitor of metalloproteinases levels in healthy and diseased sites. J Clin Periodontol 1995;22:505-9.
68. Birkedal-Hansen H. Proteolytic remodeling of the extracellular matrix. Curr Opin Cell Biol 1995;7:728-35.
69. Freije JMP, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766-73.